JAY PASSMORE: Open Payments
NPI 1063804532 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,236 in 132 payments from 19 companies in 2025. Trend: 2023 $2,003 · 2024 $2,485 · 2025 $4,236
Food & beverage: $3,012Consulting: $1,125Education: $98
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $1,438 |
| Regeneron Healthcare Solutions, Inc. | 13 | $547 |
| GENZYME CORPORATION | 6 | $455 |
| ABBVIE INC. | 16 | $296 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $261 |
| Galderma Laboratories, L.P. | 14 | $234 |
| Novartis Pharmaceuticals Corporation | 18 | $210 |
| Lilly USA, LLC | 11 | $147 |
| UCB, Inc. | 5 | $138 |
| Incyte Corporation | 3 | $81 |
Products named: TREMFYA, DUPIXENT, ILUMYA, NEMLUVIO, COSENTYX, SKYRIZI, RINVOQ, EBGLYSS.
Industry payments across TN — which companies pay providers there.
